A novel compound which sensitizes BRAF wild-type melanoma cells to vemurafenib in a TRIM16-dependent manner

- Sutton, Selina K., Carter, Daniel R., McArthur, Grant A., Cheung, Belamy B., Marshall, Glenn M., Kim, Patrick, Tan, Owen, Arndt, Greg M., Zhang, Xu Dong, Baell, Jonathan, Noll, Benjamin D., Wang, Shudong, Kumar, Naresh

Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression

- Liu, Pei Y., Erriquez, Daniela, Cheung, Belamy B., Fox, Archa, Swarbrick, Alexander, Hüttelmaier, Stefan, Kavallaris, Maria, Perini, Giovanni, Mattick, John S., Dinger, Marcel E., Liu, Tao, Marshall, Glenn M., Tee, Andrew E., Polly, Patsie, Wong, Mathew, Liu, Bing, Bell, Jessica L., Zhang, Xu D., Milazzo, Giorgio

The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs

- Liu, Pei Y., Sokolowski, Nicholas, Liu, Bing, Yang, Rui H., Guo, Xiang Y., Tee, Andrew E., Itoh, Ken, Wang, Jenny, Kavallaris, Maria, Haber, Michelle, Norris, Murray D., Cheung, Belamy B., Guo, Su T., Byrne, Jennifer A., Ziegler, David S., Marshall, Glenn M., Dinger, Marcel E., Codd, Rachel, Zhang, Xu D., Liu, Tao, Siddiqi, Faraz, Atmadibrata, Bernard, Telfer, Thomas J., Sun, Yuting, Zhang, Lihong, Yu, Denise, Mccarroll, Joshua

TRIM16 inhibits proliferation and migration through regulation of interferon beta 1 in melanoma cells

- Sutton, Selina K., Koach, Jessica, Long, Georgina V., Liu, Tao, McArthur, Grant, Zhang, Xu Dong, Scolyer, Richard A., Cheung, Belamy B., Marshall, Glenn M., Tan, Owen, Liu, Bing, Carter, Daniel R., Wilmott, James S., Yosufi, Benafsha, Haydu, Lauren E., Mann, Graham J., Thompson, John F.